Patient-Provider Distance in Medicare Outpatient Oncology Telehealth Versus Office Visits, 2021‐2023: Cross-Sectional Claims Analysis

• by Lingbo Liu, Tracy Onega, Erika L Moen, Anna N A Tosteson, Rebecca E Smith, Qianfei Wang, Lauren Cowan, Fahui Wang

• October 23, 2026

Bayesian network meta-analysis comparing efficacy of surgical gastrojejunostomy, endoscopic stenting, and EUS-guided gastroenterostomy for malignant gastric outlet obstruction

• by Zhixin Xie, Zhiyu Yan, Yunlu Feng, Aiming Yang, Wen Shi, Qiang Wang

• October 16, 2026

Diagnostic performance and pathologic associations of the UroVysion assay in patients with upper tract lesions and negative urinary cytology: a large-scale real-world study of 1,256 patients

• by Longtao Zheng, Bao Guan, Zheng Wu, Yi Ding, Bei Zhang, Xuesong Li, Yanqing Gong

• October 18, 2026

2026 ASCO Breast Cancer Highlights: persevERA

Harold Burstein, MD, PhD, and Erica Mayer, MD, MPH, discuss the persevERA trial and oral SERDS in metastatic breast cancer.

• October 15, 2026

• 1 min